Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

267
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
267
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

610
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
610
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

934
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
934
Hypothesis Test for Test of Independence01:16

Hypothesis Test for Test of Independence

5.5K
The test of independence is a chi-square-based test used to determine whether two variables or factors are independent or dependent. This hypothesis test is used to examine the independence of the variables. One can construct two qualitative survey questions or experiments based on the variables in a contingency table. The goal is to see if the two variables are unrelated (independent) or related (dependent). The null and alternative hypotheses for this test are:
H0: The two variables (factors)...
5.5K
Depressants01:28

Depressants

226
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
226
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

448
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
448

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bereavement and Loss: Understanding Grief in Older People.

The Senior care pharmacist·2024
Same author

Telehealth: Moving Older People Along the Adoption Trajectory.

The Senior care pharmacist·2023
Same author

Insomnia Is Not a Normal Part of Aging: The Challenges of Safely and Effectively Managing Insomnia in Older People.

The Senior care pharmacist·2023
Same author

Treating Erectile Dysfunction with Prescription Medications & Natural Products: A Pharmacist's Guide.

The Senior care pharmacist·2021
Same author

Skin Tears in Older People.

The Senior care pharmacist·2020
Same author

Anxiety Disorders in Older People.

The Senior care pharmacist·2020
Same journal

Can Technology Simplify Aging Care-or Just Shift the Complexity?

The Senior care pharmacist·2026
Same journal

Transitioning Medication-Related Home Visits to a Cognitively Accessible Digital Intervention in Home Care: A Practice Innovation Pilot.

The Senior care pharmacist·2026
Same journal

Perception of Technology to Support Medication Management Among Community-dwelling African American Older Adults.

The Senior care pharmacist·2026
Same journal

ASCP Policy Review Committee.

The Senior care pharmacist·2026
Same journal

Initial Evaluation of L-mMRC Severity Tool in Staging COPD in the Skilled Nursing Setting.

The Senior care pharmacist·2026
Same journal

Dispense This: How AI Is Reshaping Pharmacy's Clinical Services.

The Senior care pharmacist·2026
See all related articles

Related Experiment Video

Updated: Nov 1, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

1.2K

Alcohol-Related Dementia: Rethink How Much You Drink.

Raquel Mateus1, Jeannette Y Wick1

  • 1The University of Connecticut, Storrs, Connecticut.

The Senior Care Pharmacist
|June 19, 2021
PubMed
Summary
This summary is machine-generated.

Alcohol-related dementia (ARD) is common, often overlooked, and linked to long-term heavy drinking. Early diagnosis and thiamine treatment are key, with consultant pharmacists aiding care plans.

More Related Videos

Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication
09:26

Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication

Published on: February 6, 2019

19.2K
The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders
19:57

The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders

Published on: August 5, 2017

8.6K

Related Experiment Videos

Last Updated: Nov 1, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

1.2K
Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication
09:26

Disruption of Frontal Lobe Neural Synchrony During Cognitive Control by Alcohol Intoxication

Published on: February 6, 2019

19.2K
The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders
19:57

The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders

Published on: August 5, 2017

8.6K

Area of Science:

  • Neurology
  • Geriatrics
  • Addiction Medicine

Background:

  • Alcohol consumption is historically prevalent.
  • Clinicians recognize alcohol's potential to cause or worsen dementia.
  • Alcohol-related dementia (ARD) is underdiagnosed despite its prevalence.

Purpose of the Study:

  • To highlight the commonality and diagnostic challenges of ARD.
  • To emphasize the role of alcohol in dementia etiology and exacerbation.
  • To discuss management strategies including thiamine treatment and pharmacist involvement.

Main Methods:

  • Review of clinical observations and historical recognition of ARD.
  • Discussion of diagnostic difficulties, including patient honesty and reliance on collateral information.
  • Exploration of treatment implications, including thiamine and alcohol abstinence.

Main Results:

  • ARD develops from long-term excessive alcohol use and can progress to Wernicke-Korsakoff syndrome.
  • Accurate diagnosis is often hindered by patients' lack of truthful alcohol consumption disclosure.
  • Thiamine treatment may prevent or improve ARD symptoms, and abstinence is critical.

Conclusions:

  • Consultant pharmacists can assist healthcare teams in creating tailored care plans for ARD patients.
  • Addressing alcohol consumption is vital for managing dementia.
  • Despite challenges, ARD requires greater clinical attention and diagnostic consideration.